Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Ho Ji

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Asia-Pacific Journal of Clinical Oncology|April 1, 2016
Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinomaSung Hee Lim, In Gyu Hwang, Jun Ho Ji, et al.
Cancer Research and Treatment|February 15, 2016
Is There a Role for Adjuvant Therapy in R0 Resected Gallbladder Cancer?: A Propensity Score-Matched AnalysisSe-Il Go, Young Saing Kim, In Gyu Hwang, et al.
Inhalation Toxicology|June 24, 2008
Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facilityJeong Hee Han, Eun Jung Lee, Ji Hyun Lee, et al.
Cancer Research and Treatment|August 25, 2017
Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching AnalysisJun Ho Ji, Young Saing Kim, Inkeun Park, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 17, 2023
Dosimetric comparison between RapidArc and HyperArc in hippocampal-sparing whole-brain radiotherapy with a simultaneous integrated boostJeongho Kim, Tae Gyu Kim, Byungdo Park, et al.
The Oncologist|October 11, 2013
Treatment of dexamethasone-induced hiccup in chemotherapy patients by methylprednisolone rotationGyeong-Won Lee, Sung Yong Oh, Myoung Hee Kang, et al.
Cancer Chemotherapy and Pharmacology|July 5, 2012
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutationSu-Hee Cho, Lee Chun Park, Jun Ho Ji, et al.
Oncology|March 22, 2012
Implications of different CA 15-3 levels according to breast cancer subtype at initial diagnosis of recurrent or metastatic breast cancerSilvia Park, Hee Kyung Ahn, Lee Chun Park, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2016
Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinomaYoung Saing Kim, In Gyu Hwang, Song-Ee Park, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2013
Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasisJun Ho Ji, Se Hoon Park, Jeeyun Lee, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Asia-Pacific Journal of Clinical Oncology|April 1, 2016
Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinomaSung Hee Lim, In Gyu Hwang, Jun Ho Ji, et al.
Cancer Research and Treatment|February 15, 2016
Is There a Role for Adjuvant Therapy in R0 Resected Gallbladder Cancer?: A Propensity Score-Matched AnalysisSe-Il Go, Young Saing Kim, In Gyu Hwang, et al.
Inhalation Toxicology|June 24, 2008
Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facilityJeong Hee Han, Eun Jung Lee, Ji Hyun Lee, et al.
Cancer Research and Treatment|August 25, 2017
Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching AnalysisJun Ho Ji, Young Saing Kim, Inkeun Park, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 17, 2023
Dosimetric comparison between RapidArc and HyperArc in hippocampal-sparing whole-brain radiotherapy with a simultaneous integrated boostJeongho Kim, Tae Gyu Kim, Byungdo Park, et al.
The Oncologist|October 11, 2013
Treatment of dexamethasone-induced hiccup in chemotherapy patients by methylprednisolone rotationGyeong-Won Lee, Sung Yong Oh, Myoung Hee Kang, et al.
Cancer Chemotherapy and Pharmacology|July 5, 2012
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutationSu-Hee Cho, Lee Chun Park, Jun Ho Ji, et al.
Oncology|March 22, 2012
Implications of different CA 15-3 levels according to breast cancer subtype at initial diagnosis of recurrent or metastatic breast cancerSilvia Park, Hee Kyung Ahn, Lee Chun Park, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2016
Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinomaYoung Saing Kim, In Gyu Hwang, Song-Ee Park, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2013
Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasisJun Ho Ji, Se Hoon Park, Jeeyun Lee, et al.
Pageof 7